Novartis has a much-anticipated approval for its spinal muscular atrophy (SMA) treatment onasemnogene abeparvovec in the US, getting a green light for a new version that can make more patients ...
Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...
Ali Hussain has a background that consists of a career in finance with large financial institutions and in journalism covering business. Katrina Ávila Munichiello is an experienced editor, writer, ...